The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial
Open accessAbstract
Purpose: There is growing interest to enhance symptom monitoring during routine cancer care using patient-reported outcomes, but evidence of impact on clinical outcomes is limited. Methods: We randomly assigned patients receiving routine outpatient chemotherapy for advanced solid tumors at Memorial Sloan Kettering Cancer Center to report 12 common symptoms via tablet computers or to receive usual care consisting of symptom monitoring at the discretion of clinicians. Those with home computers received weekly e-mail prompts to report between visits. Treating physicians received symptom printouts at visits, and nurses received e-mail alerts when participants reported severe or worsening symptoms. The primary outcome was change in health-related quality of life (HRQL) at 6 months compared with baseline, measured by the EuroQol EQ-5D Index. Secondary endpoints included emergency room (ER) visits, hospitalizations, and survival. Results: Among 766 patients allocated, HRQL improved among more participants in the intervention group than usual care (34% v 18%) and worsened among fewer (38% v 53%; P < .001). Overall, mean HRQL declined by less in the intervention group than usual care (1.4- v 7.1-point drop; P < .001). Patients receiving intervention were less frequently admitted to the ER (34% v 41%; P = .02) or hospitalized (45% v 49%; P = .08) and remained on chemotherapy longer (mean, 8.2 v 6.3 months; P = .002). Although 75% of the intervention group was alive at 1 year, 69% with usual care survived the year (P = .05), with differences also seen in quality-adjusted survival (mean of 8.7 v. 8.0 months; P = .004). Benefits were greater for participants lacking prior computer experience. Most patients receiving intervention (63%) reported severe symptoms during the study. Nurses frequently initiated clinical actions in response to e-mail alerts. Conclusion: Clinical benefits were associated with symptom self-reporting during cancer care.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“generate a real-time alert notification sent to the patient's cancer care team, based on prior research.25”
From Implementation of a remote symptom monitoring pathway in oncology care: analysis of real-world experience across 33 cancer centres in France and Belgium (2024) · cites this paper as [25]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“which have demonstrated improved symptom control, quality of life, and survival when structured symptom reporting is coupled with clinician response [3,4,7]”
From Implementing UK Oncology Nursing Society–Informed Digital Symptom Triage With Episode-Based Review in Routine NHS Acute Oncology: Service Evaluation (2026) · cites this paper as [3]
The cited source says what the claim attributes to it.
In the citing paper
“Electronic patient-reported outcome (ePRO) systems have demonstrated that symptom monitoring with clinician response improves symptom control and survival [3,4].”
From Implementing UK Oncology Nursing Society–Informed Digital Symptom Triage With Episode-Based Review in Routine NHS Acute Oncology: Service Evaluation (2026) · cites this paper as [3]
The cited source says what the claim attributes to it.
In the citing paper
“The findings of this evaluation are consistent with prior trials of ePRO monitoring”
From Implementing UK Oncology Nursing Society–Informed Digital Symptom Triage With Episode-Based Review in Routine NHS Acute Oncology: Service Evaluation (2026) · cites this paper as [3]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
EuroQol: a new facility for the measurement of health-related quality of life
(1990) · Health Policy · doi:10.1016/0168-8510(90)90421-9 · Cited by 15,736
A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing Risk
Gray, R. J. (1988) · The Annals of Statistics · doi:10.1214/aos/1176350951 · Cited by 4,957
Velikova, G., Booth, L., Smith, A. B., Brown, P. M., Lynch, P., Brown, J. M., & Selby, P. J. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.06.078 · Cited by 1,382
Detmar, S. B., Muller, M. J., Schornagel, J. H., Wever, L. D. V., & Aaronson, N. K. (2002) · JAMA · doi:10.1001/jama.288.23.3027 · Cited by 1,011
Kotronoulas, G., Kearney, N., Maguire, R., Harrow, A., Domenico, D. D., Croy, S., & MacGillivray, S. A. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.53.5948 · Cited by 953
Estimation of minimally important differences in EQ-5D utility and VAS scores in cancer
Pickard, A. S., Neary, M. P., & Cella, D. F. (2007) · Health and Quality of Life Outcomes · doi:10.1186/1477-7525-5-70 · Cited by 932
Snyder, C., Aaronson, N., Choucair, A., Elliott, T. E., Greenhalgh, J., Halyard, M., Hess, R., Miller, D. M., Reeve, B., & Santana, M. (2012) · Quality of Life Research · doi:10.1007/s11136-011-0054-x · Cited by 808
Chen, J., Ou, L., & Hollis, S. J. (2013) · BMC Health Services Research · doi:10.1186/1472-6963-13-211 · Cited by 796
Valderas, J. M., Kotzeva, A., Espallargues, M., Guyatt, G., Ferrans, C. E., Halyard, M. Y., Revicki, D. A., Symonds, T., Parada, A., & Alonso, J. (2008) · Quality of Life Research · doi:10.1007/s11136-007-9295-0 · Cited by 775
Adverse Symptom Event Reporting by Patients vs Clinicians: Relationships With Clinical Outcomes
Basch, E., Jia, X., Heller, G., Leahy, A. B., Sit, L., Fruscione, M., Appawu, M., Iasonos, A. E., Atkinson, T. M., Goldfarb, S. B., et al. (2009) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djp386 · Cited by 622
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Items 501–600 of 1,001
Symptom Screening for Hospitalized Pediatric Patients With Cancer
Dupuis, L. L., Johnston, D. L., Dix, D. B., McKillop, S. J., Cook, S., Crellin‐Parsons, N., Kulkarni, K. P., Patel, S., Vanan, M., Gibson, P. J., et al. (2024) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/jamapediatrics.2024.4727 · Cited by 28
Girgis, A., Delaney, G. P., Arnold, A., Miller, A., Levesque, J. V., Kaadan, N., Carolan, M., Cook, N., Masters, K. A., Tran, T. T. D., et al. (2016) · JMIR Research Protocols · doi:10.2196/resprot.6459 · Cited by 28
Patient-Reported Outcomes and Opioid Use by Outpatient Cancer Patients
Moryl, N., Dave, V., Glare, P. A., Bokhari, A., Malhotra, V. T., Gulati, A., Hung, J., Puttanniah, V. G., Griffo, Y., Tickoo, R., et al. (2017) · Journal of Pain · doi:10.1016/j.jpain.2017.11.001 · Cited by 28
“The total patient population was divided into three groups by average 24 hour pain intensity scores: mild (1-4), moderate (5-6), and severe (7-10).”
BackgroundWhisenant, M., Williams, L. A., García-González, A., Mendoza, T. R., Shi, Q., Cleeland, C. S., Zhang, J. J., Heymach, J. V., & Simon, G. R. (2020) · JCO Oncology Practice · doi:10.1200/jop.19.00577 · Cited by 28
Sundberg, K. K., Lindström, V., Petersson, L., & Langius‐Eklöf, A. (2020) · Patient Education and Counseling · doi:10.1016/j.pec.2020.08.003 · Cited by 28
Electronic Patient-reported Outcomes During Breast Cancer Adjuvant Radiotherapy
Takala, L., Kuusinen, T.-E., Skyttä, T., Kellokumpu‐Lehtinen, P., & Barlund, M. T. (2020) · Clinical Breast Cancer · doi:10.1016/j.clbc.2020.10.004 · Cited by 28
Kuklinski, D., Vogel, J., & Geißler, A. (2021) · Health Care Management Science · doi:10.1007/s10729-020-09540-2 · Cited by 28
Electronic symptom monitoring in pediatric patients hospitalized for chemotherapy
Leahy, A. B., Schwartz, L. A., Li, Y., Reeve, B. B., Bekelman, J. E., Aplenc, R., & Basch, E. (2021) · Cancer · doi:10.1002/cncr.33617 · Cited by 28
Self-citationTolstrup, L. K., Pappot, H., Bastholt, L., Möller, S., & Dieperink, K. B. (2022) · Journal of Patient-Reported Outcomes · doi:10.1186/s41687-022-00414-5 · Cited by 28
“Moreover, patient reporting could have been monitored on a routine basis by a physician to ensure that patients were contacted in case of alerts [10, 11].”
BackgroundResultLim, C. Y. S., Laidsaar‐Powell, R., Young, J. M., Solomon, M. J., Steffens, D., Blinman, P. L., O’Loughlin, S., Zhang, Y., Butow, P. N., & The advanced-CRC survivorship authorship group (2022) · OMEGA - Journal of Death and Dying · doi:10.1177/00302228221121493 · Cited by 28
“Stepped care, which has been shown to be acceptable and feasible in cancer care (Basch et al., 2016; Butow et al., 2015, 2021), may be helpful, whereby more vulnerable CRC-A survivors with high distress/low QoL receive more intensive support.”
Harada, T., Shibuya, Y., & Kamei, T. (2022) · Japan Journal of Nursing Science · doi:10.1111/jjns.12516 · Cited by 25
Zhao, Y. W., Zhang, L., Fu, Y., Wang, M., & Zhang, L. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17041327 · Cited by 28
“Additionally, clinical research regarding cancer patients’ self-report symptoms has also indicated that routine cancer treatment resulted in symptoms that precipitated emergency room visits and hospital admissions [33].”
BackgroundResultSamuel, C. A., Smith, A. B., Elkins, W., Richmond, J., Mahbooba, Z., Basch, E., Bennett, A. V., Chung, A. E., Jonsson, M., Chen, R. C., et al. (2021) · Quality of Life Research · doi:10.1007/s11136-020-02442-4 · Cited by 27
Self-citationVettese, E., Cook, S., Soman, D., Kuczynski, S., Spiegler, B. J., Davis, H., Duong, N., Schechter, T., Dupuis, L. L., & Sung, L. (2019) · BMC Cancer · doi:10.1186/s12885-019-5662-9 · Cited by 27
Spencer, K. L., Velikova, G., Henry, A. M., Westhoff, P. G., Hall, P. S., & van der Linden, Y. M. (2019) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2019.07.009 · Cited by 27
Your data is gold – Data donation for better healthcare?
Strotbaum, V., Pobiruchin, M., Schreiweis, B., Wiesner, M., & Strahwald, B. (2019) · it - Information Technology · doi:10.1515/itit-2019-0024 · Cited by 28
“[43, 44]) can initiate discussions between patients and doctors, but can also improve medical surveillance and treatment [45].”
BackgroundRogers, S. N., Allmark, C., Bekiroglu, F., Edwards, R. T., Fabbroni, G., Flavel, R., Highet, V., Ho, M. W. S., Humphris, G. M., Jones, T. M., et al. (2020) · European Archives of Oto-Rhino-Laryngology · doi:10.1007/s00405-020-06077-6 · Cited by 27
van der Willik, E. M., van Zwet, E. W., Hoekstra, T., van Ittersum, F. J., Hemmelder, M. H., Zoccali, C., Jager, K. J., Dekker, F. W., & Meuleman, Y. (2020) · Nephrology · doi:10.1111/nep.13761 · Cited by 26
Assessing the Feasibility of a Novel mHealth App in Hematopoietic Stem Cell Transplant Patients
Racioppi, A., Dalton, T., Ramalingam, S., Romero, K. M., Ren, Y., Bohannon, L. M., Arellano, C., Jonassaint, J., Miller, H. M., Barak, I., et al. (2020) · Transplantation and Cellular Therapy · doi:10.1016/j.jtct.2020.10.017 · Cited by 26
Appleyard, S. E., Larkin, M., Stewart, E., Minton, O., & Gilbert, D. C. (2021) · Clinical Oncology · doi:10.1016/j.clon.2021.04.008 · Cited by 28
“These systems demonstrate however that PRO use in routine care is both possible and acceptable with evidence of improved symptom management, treatment completion and even overall survival (12,15 – 18).”
BackgroundLapen, K., Sabol, C., Tin, A. L., Lynch, K. A., Kassa, A., Mabli, X., Ford, J., Cha, E., Bernstein, M. B., Braunstein, L. Z., et al. (2021) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2021.07.1692 · Cited by 28
Huynh-Dagher, S., Blom, A., Chabanol, H., & Funck‐Brentano, E. (2021) · International Journal of Women’s Dermatology · doi:10.1016/j.ijwd.2021.09.009 · Cited by 27
ElMokhallalati, Y., Alaloul, E., Shatat, M., Shneewra, T., Massri, S. E., Shaer, O., Relton, S. D., Abu‐Odah, H., & Allsop, M. J. (2022) · PLoS ONE · doi:10.1371/journal.pone.0262512 · Cited by 27
Viecelli, A. K., Duncanson, E., Bennett, P. N., D’Antoine, M., Dansie, K. B., Handke, W. A., Tong, A., Palmer, S. C., Jesudason, S., McDonald, S. P., et al. (2022) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2021.12.007 · Cited by 29
Lindvall, C. J., Deng, C.-Y., Agaronnik, N. D., Kwok, A., Samineni, S., Umeton, R., Mackie-Jenkins, W., Kehl, K. L., Tulsky, J. A., & Enzinger, A. C. (2022) · JCO Clinical Cancer Informatics · doi:10.1200/cci.21.00136 · Cited by 29
“Symptoms have a major effect on patients’ quality of life,(1,2) treatment tolerance, and prognosis.(3,4) Symptoms are therefore critical outcomes to monitor in therapeutic clinical trials, observational research, and population-level surveillance.”
BackgroundA modified Edmonton Symptom Assessment Scale for symptom clusters in radiation oncology patients
Johnstone, P. A. S., Lee, J., Zhou, J., Ma, Z., Portman, D. G., Jim, H., & Tsai, Y.-Y. (2017) · Cancer Medicine · doi:10.1002/cam4.1125 · Cited by 27
“Moreover, patients and providers report high satisfaction with symptom monitoring [1, 2], indicating that it results in improved communication about symptoms with little to no additional burden.”
BackgroundTelehealth in older adults with cancer in the United States: The emerging use of wearable sensors
Shen, J., & Naeim, A. (2017) · Journal of Geriatric Oncology · doi:10.1016/j.jgo.2017.08.008 · Cited by 28
Use of patient-reported outcomes in regional cancer centres over time: a retrospective study
Barbera, L. C., Lee, F., & Sutradhar, R. (2019) · CMAJ Open · doi:10.9778/cmajo.20180074 · Cited by 27
Stabellini, N., Nazha, A., Agrawal, N., Huhn, M., Shanahan, J., Hamerschlak, N., Waite, K. A., Barnholtz‐Sloan, J. S., & Montero, A. J. (2023) · JCO Clinical Cancer Informatics · doi:10.1200/cci.22.00143 · Cited by 29
An Integrated Care Approach to Improve Well-Being in Breast Cancer Patients
Fabi, A., Rossi, A., Mocini, E., Cardinali, L., Bonavolontá, V., Cenci, C., Magno, S., Barberi, V., Moretti, A., Besharat, Z. M., et al. (2024) · Current Oncology Reports · doi:10.1007/s11912-024-01500-1 · Cited by 30
“An important change is represented using the Patient Reported Outcome Measures (PROMs-e-PROMs), related to health status reported directly by the patient, without the mediation of the clinical interview that often leads to underestimating effects [113].”
MethodEngagement Among Diverse Patient Backgrounds in a Remote Symptom Monitoring Program
Rocque, G. B., Caston, N. E., Hildreth, K., Deng, L., Henderson, N. L., Williams, C., Azuero, A., Jackson, B. E., Franks, J. A., McGowan, C., et al. (2024) · JCO Oncology Practice · doi:10.1200/op.24.00066 · Cited by 25
Self-citationOlson, R. A., Howard, A. F., Lapointe, V., Schellenberg, D. D., Nichol, A., Bowering, G., Curtis, S., Walter, A., Brown, S., Thompson, C., et al. (2017) · Healthcare Management Forum · doi:10.1177/0840470417715478 · Cited by 27
Pain management index (PMI)—does it reflect cancer patients’ wish for focus on pain?
Thronæs, M., Balstad, T. R., Brunelli, C., Løhre, E. T., Klepstad, P., Vagnildhaug, O. M., Kaasa, S., Knudsen, A. K., & Solheim, T. S. (2019) · Supportive Care in Cancer · doi:10.1007/s00520-019-04981-0 · Cited by 26
Patient-Reported Outcomes in Integrative Oncology
Lopez, G., Lacey, J., Christie, A. J., Powers-James, C. R., Narayanan, S., Liu, W., & Cohen, L. G. (2019) · The Cancer Journal · doi:10.1097/ppo.0000000000000401 · Cited by 26
Kirchheiner, K., Pötter, R., Nout, R. A., Vittrup, A. S., Holzner, B., Bentzen, S. M., & Tanderup, K. (2019) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2019.10.027 · Cited by 26
McFarland, D. C., Jutagir, D. R., Miller, A. H., & Nelson, C. J. (2020) · Psycho-Oncology · doi:10.1002/pon.5367 · Cited by 27
Graboyes, E. M., Hand, B. N., Ellis, M. A., Huang, A. T., Nilsen, M. L., Pipkorn, P. J., Marsh, C. H., Maurer, S. N., Day, T. A., & Sterba, K. R. (2020) · Otolaryngology · doi:10.1177/0194599820927364 · Cited by 26
“PROMs enhance the delivery of patient-centered HNC care(22) and result in improved symptom control, higher levels of patient satisfaction, and decreased mortality when incorporated into clinical oncology practice.(23,24) The paradigm shift toward measuring BID using PROMs, which harness the patient’s words and experie…”
BackgroundKaufmann, T. L., Rendle, K. A. S., Aakhus, E., Nimgaonkar, V. U., Shah, A., Bilger, A., Gabriel, P. E., Trotta, R. L., Braun, J., Shulman, L. N., et al. (2020) · JCO Oncology Practice · doi:10.1200/op.20.00013 · Cited by 26
Kyte, D. G., Anderson, N. E., Auti, R., Aiyegbusi, O. L., Bishop, J. R. B., Bissell, A., Brettell, E. A., Calvert, M., Chadburn, M., Cockwell, P., et al. (2020) · Journal of Patient-Reported Outcomes · doi:10.1186/s41687-020-00223-8 · Cited by 28
“We intend to explore the experiences of patients using RePROM, compared to those documented using the aforementioned ePROM systems in renal disease [17, 18] and cancer [12, 13].”
Mouillet, G., Falcoz, A., Fritzsch, J., Almotlak, H., Jacoulet, P., Pivot, X. B., Villanueva, C., Mansi, L., Kim, S. C. H., Curtit, E., et al. (2021) · Quality of Life Research · doi:10.1007/s11136-020-02721-0 · Cited by 25
Patient-Reported Outcomes and Long-Term Nonadherence to Aromatase Inhibitors
Hershman, D. L., Neugut, A. I., Moseley, A. B., Arnold, K. B., Gralow, J. R., Henry, N. L., Hillyer, G. C., Ramsey, S. D., & Unger, J. M. (2021) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djab022 · Cited by 26
“AI nonadherence was greater at 36 months among those with more baseline endocrine symptoms, higher pain, and worse HRQOL.”
MethodInfluentialSymptom Diaries of Patients with Midgut Neuroendocrine Tumors Treated with 177Lu-DOTATATE
Strosberg, J., Srirajaskanthan, R., El-Haddad, G. E., Wolin, E. M., Chasen, B. A., Kulke, M. H., Bushnell, D. L., Caplin, M. E., Baum, R. P., Hendifar, A. E., et al. (2021) · Journal of Nuclear Medicine · doi:10.2967/jnumed.120.258897 · Cited by 26
“a positive PROmeasures outcome in cancer trials (17).”
BackgroundSibert, N. T., Kowalski, C., Pfaff, H., Wesselmann, S., & Breidenbach, C. (2021) · BMC Health Services Research · doi:10.1186/s12913-021-06361-z · Cited by 27
“These instruments are called patientreported outcomes (PROs), and many clinical trials have already shown that they have benefits for monitoring purposes [3].”
BackgroundLeppla, L., Schmid, A., Valenta, S., Mielke, J., Beckmann, S., Ribaut, J., Teynor, A., Dobbels, F., Duerinckx, N., Zeiser, R., et al. (2021) · Supportive Care in Cancer · doi:10.1007/s00520-021-06328-0 · Cited by 29
“In cancer patients, eHealth-facilitated care models integrating two or more eCCM dimensions led to, e.g., reduced symptom burden [18], re-hospitalizations, improved survival, quality of life [19, 20], and physical activity [21].”
BackgroundTsangaris, E., Edelen, M. O., Means, J., Gregorowitsch, M. L., O’Gorman, J., Pattanaik, R., Dominici, L. S., Hassett, M. J., Witkowski, M. L., Schrieber, K., et al. (2022) · BMJ Surgery Interventions & Health Technologies · doi:10.1136/bmjsit-2021-000119 · Cited by 32
Engaging TEAM Medicine in Patient Care: Redefining Cancer Survivorship From Diagnosis
Alfano, C. M., Oeffinger, K. C., Sanft, T. B., & Tortorella, B. (2022) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_349391 · Cited by 26
Dyer, N. L., Surdam, J., Srinivasan, R., Agarwal, A., & Dusek, J. A. (2022) · Journal of Integrative and Complementary Medicine · doi:10.1089/jicm.2021.0413 · Cited by 26
“9 In the case of chronic and/or terminal illness where no effective cure is available, or may only modestly prolong life, treatment emphasis is often placed on improving health-related quality of life.”
Cella, D. F., Garcia, S. F., Cahue, S., Smith, J. D., Yanez, B. R., Scholtens, D. M., Lancki, N., Bass, M., Kircher, S. M., Flores, A. M., et al. (2023) · Contemporary Clinical Trials · doi:10.1016/j.cct.2023.107171 · Cited by 28
Chera, B. S., Fried, D., Price, A. T., Amdur, R. J., Mendenhall, W. M., Lu, C., Das, S. K., Sheets, N. C., Marks, L. B., & Mavroidis, P. (2017) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2017.03.034 · Cited by 26
Cella, D. F., Traina, S., Li, T., Johnson, K., Ho, K. F., Molina, A., & Shore, N. D. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx759 · Cited by 26
Toxicity of Cancer Therapies in Older Patients
Saux, O. L., & Falandry, C. (2018) · Current Oncology Reports · doi:10.1007/s11912-018-0705-y · Cited by 26
Sterba, K. R., Armeson, K. E., Zapka, J., Scallion, M. L., Garris, T. K., Graboyes, E. M., Ruggiero, K. J., & Day, T. A. (2019) · Journal of Cancer Survivorship · doi:10.1007/s11764-019-0732-1 · Cited by 26
Holländer-Mieritz, C., Johansen, J., Johansen, C., Vogelius, I. R., Kristensen, C. A., & Pappot, H. (2019) · Acta Oncologica · doi:10.1080/0284186x.2018.1563713 · Cited by 26
“This approach has recently been performed with success during chemotherapy of metastatic cancer disease [2] and follow-up of lung cancer [3], both studies using schedules including 12 questions and showing significant improvement on survival using PRO [1,3].”
BackgroundInSight Care Pilot Program: Redefining Seeing a Patient
Daly, B., Kuperman, G. J., Zervoudakis, A., Medsker, A. B., Roy, A., Ro, A. S., Arenas, J. M., Yanamandala, H. V., Kottamasu, R., Salvaggio, R., et al. (2020) · JCO Oncology Practice · doi:10.1200/op.20.00214 · Cited by 26
“Eligible patients (1) were 18 years of age or older; (2) had a diagnosis of a solid tumor or lymphoma; (3) were starting intravenous antineoplastic therapy, including a cytotoxic, immunologic, or biologic agent, that was initial therapy or had been at least 6 months since their last treatment; (4) had access to a smar…”
BackgroundUsing Technology to Improve Cancer Care: Social Media, Wearables, and Electronic Health Records
Fisch, M. J., Chung, A. E., & Accordino, M. K. (2016) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_156682 · Cited by 27
Price, G., van Herk, M., & Faivre-Finn, C. (2017) · Clinical Oncology · doi:10.1016/j.clon.2017.07.011 · Cited by 25
Why focus on patient-reported outcome measures in older colorectal cancer patients?
Doolin, J. W., Halpin, M., Berry, J. L., Hshieh, T. T., & Zerillo, J. A. (2019) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2019.07.028 · Cited by 25
Pugh, S. L., Rodgers, J. P., Yeager, K. A., Chen, R. C., Movsas, B., Bonanni, R., Dignam, J. J., & Bruner, D. W. (2020) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2020.06.030 · Cited by 25
Magalhães, B. M. B. D. S., Fernandes, C. S., Martínez‐Galiano, J. M., & Santos, C. (2020) · International Journal of Medical Informatics · doi:10.1016/j.ijmedinf.2020.104293 · Cited by 32
Lagergren, P., Johar, A. M., Rosenlund, H., Arnberg, L., Haglund, L., Ness‐Jensen, E., & Schandl, A. R. (2021) · Journal of Cancer Survivorship · doi:10.1007/s11764-020-00974-9 · Cited by 26
Completion of Patient-Reported Outcome Questionnaires Among Older Adults with Advanced Cancer
Flannery, M. A., Mohile, S. G., Culakova, E., Norton, S. A., Kamen, C. S., Dionne-Odom, J. N., DiGiovanni, G., Griggs, L., Bradley, T. P., Hopkins, J. O., et al. (2021) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2021.07.032 · Cited by 25
Oster, H. S., Crouch, S., Smith, A. G., Yu, G., Shrkihe, B. A., Baruch, S., Kolomansky, A., Ben‐Ezra, J. M., Naor, S., Fenaux, P., et al. (2021) · Blood Advances · doi:10.1182/bloodadvances.2020004055 · Cited by 25
Emerging digital technologies in cancer treatment, prevention, and control
Hesse, B. W., Kwaśnicka, D., & Ahern, D. K. (2021) · Translational Behavioral Medicine · doi:10.1093/tbm/ibab033 · Cited by 29
“…use the powerful analytic capabilities made possible through just-in-time data analytic systems to intervene early when adverse events are detected [34] and to help hospital administrators allocate scarce resources proactively to those at highest risk for worse outcomes and in greatest need [93].”
BackgroundDIGITAL THERAPEUTICS IN ONCOLOGY: FINDINGS, BARRIERS AND PROSPECTS. A NARRATIVE REVIEW
Gussoni, G., Ravot, E., Zecchina, M., Recchia, G., Santoro, E., R., A., & Perrone, F. (2022) · Annals of Research in Oncology · doi:10.48286/aro.2022.39 · Cited by 23
Nipp, R. D., Shulman, E., Smith, M. H., Brown, P. M. C., Johnson, P. C., Gaufberg, E., Vyas, C., Qian, C. L., Neckermann, I., Hornstein, S., et al. (2022) · BMC Cancer · doi:10.1186/s12885-022-09461-z · Cited by 25
Real-World Adherence to Patient-Reported Outcome Monitoring as a Cancer Care Quality Metric
Takvorian, S. U., Anderson, R. T., Gabriel, P. E., Poznyak, D., Lee, S., Simon, S., Barrett, K. A., & Shulman, L. N. (2022) · JCO Oncology Practice · doi:10.1200/op.21.00855 · Cited by 25
“We limited our sample to those receiving active treatment given the particularly strong evidence base for PRO symptommonitoring in this population.(1-3,5) The primary outcome was patient-level adherence to PRO monitoring, defined for each participant as the proportion of active treatment visits during which a PRO ques…”
BackgroundMethodNordhausen, T., Lampe, K., Vordermark, D., Holzner, B., Al‐Ali, H. K., Meyer, G., & Schmidt, H. (2022) · Journal of Patient-Reported Outcomes · doi:10.1186/s41687-022-00478-3 · Cited by 25
Ni, R., Liu, M., Huang, S., & Yang, J. (2022) · Journal of Medical Internet Research · doi:10.2196/40090 · Cited by 25
“With the increasing social demand for electronic technology, the use of mobile devices has the great potential to transform conventional health care and implement patient-centered initiatives [15-17].”
BackgroundPerry, L. M., Morken, V., Peipert, J. D., Yanez, B. R., Garcia, S. F., Barnard, C., Hirschhorn, L. R., Linder, J. A., Jordan, N., Ackermann, R. T., et al. (2022) · JMIR Research Protocols · doi:10.2196/38461 · Cited by 30
“In particular, our dashboard aims to improve recognition and shared decision-making for the management of patients’ symptoms and treatment needs, which can promote more effective use of the health care system and translate into improved patient outcomes [17,18,29,76].”
BackgroundA Review of Patient-Reported Outcome Measures in Childhood Cancer
Horan, M. R., Sim, J.-A., Krull, K. R., Baker, J. N., & Huang, I. (2022) · Children · doi:10.3390/children9101497 · Cited by 25
“Collecting patient-reported symptoms is especially meaningful and clinically actionable, which has shown HRQOL improvement for adult cancer patients [50].”
BackgroundBraulke, F., Para, S., Alt‐Epping, B., Tewes, M., Bäumer, M., Haberland, B., Mayer‐Steinacker, R., Hopprich, A., de Wit, M., Grabe, M., et al. (2023) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-023-04818-8 · Cited by 25
Billingy, N. E., Tromp, V. N. M. F., Aaronson, N. K., Hoek, R. J. A., Bogaard, H. J., Onwuteaka-Philipsen, B. D., van de Poll-Franse, L. V., Hugtenburg, J. G., Belderbos, J. S. A., Becker‐Commissaris, A., et al. (2023) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djad159 · Cited by 26
“Our findings are consistent with earlier studies on PRO symptom monitoring, which reported similar results with respect to HRQOL in metastatic cancer patients (7,11,26), curatively treated patients (27), and lung cancer patients (9).”
BackgroundResultHarrison, C. J., Trickett, R. W., Wormald, J. C. R., Dobbs, T. D., Lis, P., Popov, V., Beard, D. J., & Rodrigues, J. N. (2023) · Journal of Medical Internet Research · doi:10.2196/47179 · Cited by 25
“These sampling frequencies exceed those typically reported by studies aiming to monitor patients with traditional PROMs of similar lengths to the PEM [9,17,45,46].”
Evaluation of clinical decision support systems in oncology: An updated systematic review
Nafees, A., Khan, M., Chow, R., Fazelzad, R., Hope, A. J., Liu, G., Létourneau, D., & Raman, S. (2023) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2023.104143 · Cited by 24
Govindaraj, R., Agar, M. R., Currow, D. C., & Luckett, T. (2023) · Journal of Medical Internet Research · doi:10.2196/48483 · Cited by 27
“The risk of bias in the abovementioned RCTs, contributing to the testing of program theory 3, concerns the lack of blinding in all the studies (n=21) and significant attrition and missing outcomes in the studies by Basch et al [4], Greer et al [88], and Absolom et al [78].”
InfluentialTelemedicine-Enabled Clinical Trial of Metformin in Patients With Prostate Cancer
Galsky, M. D., Shahin, M., Jia, R., Shaffer, D. R., Gimpel-Tetra, K., Tsao, C., Baker, C., Leiter, A., Holland, J., Sablinski, T., et al. (2017) · JCO Clinical Cancer Informatics · doi:10.1200/cci.17.00044 · Cited by 25
Digital Follow-Up and the Perspective of Patient-Centered Care in Oncology: What’s the PROblem?
Giordano, F. A., Welzel, G., Siefert, V., Jahnke, L., Ganslandt, T., Wenz, F. K., Grosu, A., Heinemann, F. E., & Nicolay, N. H. (2018) · Oncology · doi:10.1159/000495294 · Cited by 26
Phillips, S. A., Ali, M. M., Modrich, C., Oke, S., Elokda, A. S., Laddu, D., & Bond, S. (2018) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2018.12.007 · Cited by 27
Kuklinski, D., Oschmann, L., Pross, C. M., Busse, R., & Geißler, A. (2020) · Trials · doi:10.1186/s13063-020-04252-y · Cited by 25
COVID-19 and Cancer Care: Ensuring Safety While Transforming Care Delivery
Mulvey, T. M., & Jacobson, J. O. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.20.01474 · Cited by 25
Yap, C., Aiyegbusi, O. L., Alger, E., Basch, E., Bell, J. A., Bhatnagar, V., Cella, D. F., Collis, P., Dueck, A. C., Gilbert, A., et al. (2024) · EClinicalMedicine · doi:10.1016/j.eclinm.2024.102838 · Cited by 26
“35,36 Though somewhat different than ad hoc reporting, these results may indicate promise for the ability of ad hoc PRO reports to have clinical value, though this would require testing.”
BackgroundSelf-citationTransforming healthcare delivery with conversational AI platforms
Mahajan, A., & Powell, D. (2025) · npj Digital Medicine · doi:10.1038/s41746-025-01968-6 · Cited by 26
Giesinger, J., Aaronson, N., Arraras, J., Efficace, F., Groenvold, M., Kieffer, J., Loth, F., Petersen, M., Ramage, J., Tomaszewski, K., et al. (2018) · Psycho-Oncology · doi:10.1002/pon.4548 · Cited by 22
“has been shown to be feasible and associated with a number of clinical benefits including fewer hospitalizations and superior quality adjusted survival.(5) However, the interpretation of scores derived from PRO questionnaires is often challenging for patients and HCPs, partly because results are given on metrics (eg,…”
BackgroundDusek, J. A., JaKa, M. M., Wallerius, S., Fairchild, S., Victorson, D. E., Rivard, R. L., & Betzner, A. E. (2018) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2018.01.012 · Cited by 24
Isa, F., Turner, G., Kaur, G., Kyte, D. G., Slade, A. L., Pankhurst, T., Kerecuk, L., Keeley, T., Ferguson, J., & Calvert, M. (2018) · Health and Quality of Life Outcomes · doi:10.1186/s12955-018-0951-6 · Cited by 25
Rasschaert, M. A., Vulsteke, C., Keersmaecker, S. D., Vandenborne, K., Dias, S., Verschaeve, V., Vuylsteke, P., Brussel, I. V., Ravelingien, J., van Dam, P. A., et al. (2020) · Supportive Care in Cancer · doi:10.1007/s00520-020-05550-6 · Cited by 24
“Examples of successful implementation of electronic symptom/toxicity reporting tools based on patient adapted version of the CTCAE include Patient Viewpoint, the symptom tracking and reporting system (STAR) system for patients to report chemotherapy AE and the Tell Us system® for patients in hospices (both in the USA)…”
MethodResultInfluentialIntegrating Patient‐Reported Outcomes Within Routine Hepatology Care: A Prompt to Action
Verma, M., & Younossi, Z. M. (2020) · Hepatology · doi:10.1002/hep.31550 · Cited by 24
Bhat, G. R., Karakasis, K., & Oza, A. M. (2020) · Cancers · doi:10.3390/cancers12113296 · Cited by 23
“Data show that integration of electronic PRO into routine care of recurrent metastatic cancer is associated with survival improvement and may be considered as part of high-quality cancer care [59].”
BackgroundBiran, N., Kouyaté, R. A., Yücel, E., McGovern, G. E., Schoenthaler, A., Durling, O. G., Unawane, R., Schutt, A., & Panjabi, S. S. (2020) · JMIR Formative Research · doi:10.2196/18982 · Cited by 22
“One study, conducted at Memorial Sloan Kettering Cancer Center among patients initiating chemotherapy for certain metastatic solid tumors, found that patients using an ePRO system had greater improvement in health-related quality of life, were less frequently admitted to the emergency department or hospital, remained…”
BackgroundMethodInfluentialSibert, N. T., Pfaff, H., Breidenbach, C., Wesselmann, S., & Kowalski, C. (2021) · Cancers · doi:10.3390/cancers13163964 · Cited by 24
Noel, C. W., Eskander, A. E., Sutradhar, R., Mahar, A. L., Vigod, S. N., Isenberg‐Grzeda, E., Bolton, J. M., Deleemans, J. M., Chan, W. C., Vasdev, R., et al. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.26822 · Cited by 24
Digital Health for Patients With Multiple Myeloma: An Unmet Need
Jagannath, S., Mikhael, J. R., Nadeem, O., & Raje, N. S. (2021) · JCO Clinical Cancer Informatics · doi:10.1200/cci.20.00145 · Cited by 24
Reducing the pressures of outpatient care: the potential role of patient-reported outcomes
Aiyegbusi, O. L., Hughes, S., Peipert, J. D., Schougaard, L. M. V., Wilson, R., & Calvert, M. (2023) · Journal of the Royal Society of Medicine · doi:10.1177/01410768231152222 · Cited by 24
Lee, M., Kang, D., Kang, E., Kim, S.-Y., Kim, Y., Ahn, J. S., Park, S., Lee, Y.-Y., Oh, D., Noh, J. M., et al. (2023) · Supportive Care in Cancer · doi:10.1007/s00520-023-07779-3 · Cited by 29
“However, previous randomized controlled trials on ePRO have not evaluated the improvement of patient participation, which is an important mediator in regular clinic visits [4, 13, 15, 18, 19, 24].”
BackgroundRiedl, D., Lehmann, J., Rothmund, M., Dejaco, D., Grote, V., Fischer, M. J., Rumpold, G., Holzner, B., & Licht, T. (2023) · Journal of Medical Internet Research · doi:10.2196/49476 · Cited by 24
“These results are encouraging given the numerous studies that have highlighted the benefits of using ePROs in oncology [44-46].”
Improving cancer patient emergency room utilization: A New Jersey state assessment
Scholer, A. J., Mahmoud, O., Ghosh, D., Schwartzman, J., Farooq, M., Cabrera, J., Wieder, R., Adam, N. R., & Chokshi, R. J. (2017) · Cancer Epidemiology · doi:10.1016/j.canep.2017.09.006 · Cited by 25
Kyte, D. G., Bishop, J. R. B., Brettell, E. A., Calvert, M., Cockwell, P., Dutton, M., Eddington, H., Hadley, G., Ives, N. J., Jackson, L. J., et al. (2018) · BMJ Open · doi:10.1136/bmjopen-2018-026080 · Cited by 24
Lapin, B. R., Honomichl, R. D., Thompson, N. R., Rose, S. L., Sugano, D., Udeh, B. L., & Katzan, I. L. (2019) · Value in Health · doi:10.1016/j.jval.2019.02.007 · Cited by 25
Brunelli, C., Borreani, C., Caraceni, A. T., Roli, A., Bellazzi, M., Lombi, L., Zito, E., Pellegrini, C., Spada, P., Kaasa, S., et al. (2020) · Health and Quality of Life Outcomes · doi:10.1186/s12955-020-01501-1 · Cited by 26
mHealth: Mobile Technologies to Virtually Bring the Patient Into an Oncology Practice
Pennell, N. A., Dicker, A. P., Tran, C. N., Jim, H., Schwartz, D. L., & Stepanski, E. J. (2017) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_176093 · Cited by 26
Metadata
- Authors
- Basch, E., Deal, A. M., Kris, M. G., Scher, H. I., Hudis, C. A., Sabbatini, P., Rogak, L., Bennett, A. V., Dueck, A. C., Atkinson, T. M., Chou, J. F., Dulko, D., Sit, L., Barz, A., Novotny, P., Fruscione, M., Sloan, J. A., & Schrag, D.
- Affiliations
- University of North Carolina at Chapel Hill (US)
- Ethan Basch, Mark G. Kris, Howard I. Scher, Clifford A. Hudis, Paul Sabbatini, Lauren Rogak, Thomas M. Atkinson, Joanne F. Chou, Dorothy Dulko, Laura Sit, Michael Fruscione, and Deborah Schrag, Memorial Sloan Kettering Cancer Center, New York, NY; Ethan Basch, Allison M. Deal, and Antonia V. Bennett, University of North Carolina, Chapel Hill, NC; Amylou C. Dueck, Mayo Clinic, Scottsdale, AZ; Allison Barz, Children’s Hospital of Philadelphia, Philadelphia, PA; Paul Novotny and Jeff A. Sloan, Mayo Clinic,...
- ORCID
- Venue
- Journal of Clinical Oncology
- Published
- 2016-02-20
- Volume
- 34
- Issue
- 6
- Pages
- 557-565
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- PMC
- PMC4872028
- OpenAlex
- W2195040438
- Cited by
- 2,593
- References
- 36
- Citations by year
- 2026: 252 · 2025: 263 · 2024: 321 · 2023: 288 · 2022: 316 · 2021: 299 · 2020: 292 · 2019: 191 · 2018: 180 · 2017: 143 · 2016: 44
- FWCI
- 53.87
- Type
- journal article
- Language
- en
- Update notices
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Clinical Oncology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Memorial Sloan-Kettering Cancer Center
- Society of Memorial Sloan Kettering
- National Cancer Institute (P30CA008748, P30CA015083, P30CA016086)
- Topics
- Health Sciences › Medicine › Oncology › Cancer survivorship and care
- Health Sciences › Health Professions › General Health Professions › Mobile Health and mHealth Applications
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Opioid Use
- Keywords
- patient-reported outcomes, symptom monitoring, cancer chemotherapy, health-related quality of life, advanced solid tumors, e-mail alerts, emergency department visits, hospitalization, survival, quality-adjusted survival, computer literacy, outpatient oncology
- MeSH terms
- Adult, Aged, Aged, 80 and over, Ambulatory Care, Antineoplastic Agents, Emergency Service, Hospital, Female, Hospitalization, Humans, Male, Middle Aged, Neoplasms, Quality of Life, Survival Rate, Internet, Nurse's Role, Electronic Mail, Self Report, Symptom Assessment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review